Related references
Note: Only part of the references are listed.Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring
Uwe Troeger et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Augmented renal clearance in septic patients and implications for vancomycin optimisation
Joao Pedro Baptista et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock
Julie M. Varghese et al.
CRITICAL CARE CLINICS (2011)
ARC - Augmented Renal Clearance
Andrew A. Udy et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Pharmacokinetic issues for antibiotics in the critically ill patient
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Antibacterial dosing in intensive care - Pharmacokinetics, degree of disease and pharmacodynamics of sepsis
Jason A. Roberts et al.
CLINICAL PHARMACOKINETICS (2006)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection
JD Knudsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
